SPG21

Maspardin (SPG21/ACP33) is a cytoplasmic and trans-Golgi network/late endosomal protein that functions in intracellular protein transport and sorting (PMID:14564668, PMID:19184135). It contains a noncatalytic alpha/beta hydrolase fold domain that mediates direct interaction with the cytoplasmic tail of CD4, negatively modulating CD4-dependent T cell costimulation (PMID:11113139). Maspardin also binds the aldehyde dehydrogenase ALDH16A1, with which it colocalizes in endosomal/Golgi compartments (PMID:19184135). A homozygous frameshift mutation in SPG21 (601insA) causes Mast syndrome, an autosomal recessive hereditary spastic paraplegia with dementia (PMID:14564668).

1. 2000 Medium

   The first molecular function attributed to maspardin was as an intracellular negative regulator of CD4 signaling, establishing that its alpha/beta hydrolase fold domain mediates a direct protein–protein interaction rather than catalysis.

   Evidence Yeast two-hybrid screen, co-immunoprecipitation, deletion mutagenesis, and T cell activation assays in vitro

   PMID:11113139

   Open questions at the time

   • Interaction identified in a single lab without independent replication
   • Endogenous complex stoichiometry and physiological relevance in primary T cells not established
   • Whether the hydrolase fold retains any residual catalytic activity remains untested
2. 2003 High

   Genetic mapping of Mast syndrome to SPG21 established maspardin as essential for neuronal maintenance and linked its loss to hereditary spastic paraplegia with dementia, placing the protein's transport/sorting function in a disease context.

   Evidence Positional cloning in an Amish pedigree with homozygous frameshift mutation (601insA) confirmed across 14 affected individuals

   PMID:14564668

   Open questions at the time

   • Molecular mechanism by which loss of maspardin leads to corticospinal tract degeneration is unknown
   • No rescue experiment or animal model reported in this study
   • Specific cargo sorted by maspardin-containing vesicles not identified
3. 2009 Medium

   Identification of ALDH16A1 as a maspardin binding partner expanded the protein's interactome beyond CD4 and suggested a functional connection between endosomal/Golgi trafficking and aldehyde metabolism.

   Evidence Immunoprecipitation followed by mass spectrometry, reciprocal co-IP of overexpressed proteins, fusion protein pull-down, and confocal colocalization

   PMID:19184135

   Open questions at the time

   • Functional consequence of the maspardin–ALDH16A1 interaction is unknown
   • Interaction validated only with overexpressed or tagged proteins; endogenous validation at physiological levels lacking
   • Whether ALDH16A1 binding is relevant to the Mast syndrome phenotype is untested

• The precise cargo(s) sorted by maspardin in endosomal/trans-Golgi trafficking, the structural basis of its protein interactions, and the cellular pathway connecting maspardin loss to neurodegeneration remain unresolved.
• No animal or neuronal model characterizing maspardin loss-of-function phenotypes at the cellular level
• No structural model of maspardin or its complexes
• Relationship between the CD4 and ALDH16A1 interactions and neuronal function is unclear